Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study

Creative Commons License

Ozen M., Ustun C., Ozturk B., TOPÇUOĞLU P., Arat M., Gunduz M., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.34, sa.1, ss.16-26, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 1
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4274/tjh.2015.0346
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.16-26
  • Anahtar Kelimeler: Chronic myeloid leukemia, Allogeneic transplantation, Tyrosine kinase inhibitors, Hematologic remission, STEM-CELL TRANSPLANTATION, CHRONIC MYELOGENOUS LEUKEMIA, IMATINIB ERA, CML, IMPACT, IV
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Tyrosine kinase inhibitors (TKIs) have changed the indications for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in chronic myeloid leukemia (CML). Therefore, we aimed to evaluate the effect of TKIs on allo-HSCT in CML.